Insider · CIK 0001952535
Tara DeSilva
Files at ZSQR (Coeptis Therapeutics Holdings, Inc.). First filing Jan 16, 2024, latest Jan 16, 2024.
In brief
Tara DeSilva files SEC Form 4 as director at ZSQR (Coeptis Therapeutics Holdings, Inc.). Since Jan 16, 2024, Tara DeSilva has reported 1 open-market buy worth $1,305 and 0 open-market sells worth $0, the latest filed on Jan 16, 2024.
A track record needs three past buys with six months of prices behind them; Tara DeSilva has 0, so none is measured yet.
The newest scored trade: bought $1,305 of ZSQR on Jan 12, 2024, filed Jan 16, 2024, scored 51 (moderate).
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
ZSQR: Coeptis Therapeutics Holdings, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 51Moderate | Coeptis Therapeutics Holdings, Inc. | $1,305 2,266 shares | +8% | +2% from low-72% from high |
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Feb 11, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | MOption exercise Common stock | +5,700 | $10.56 | $60k | 8,950 | Feb 13, 2026 |
| Feb 11, 2026 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Common Stock | +3,250 | $0.00 | $0 | 8,950 | Feb 13, 2026 |
| Mar 4, 2025 | ZSQR Coeptis Therapeutics Holdings, Inc. | AGrant or award Non-qualified Stock Options (right to buy)derivative | +5,700 | - | - | 8,950 | Mar 6, 2025 |
| Jan 12, 2024 | ZSQR Coeptis Therapeutics Holdings, Inc. | POpen-market purchase Common Stock | +466 | $0.56 | $261 | 30,466 | Jan 16, 2024 |
| Jan 12, 2024 | ZSQR Coeptis Therapeutics Holdings, Inc. | POpen-market purchase Common Stock | +1,800 | $0.58 | $1,044 | 32,266 | Jan 16, 2024 |
Questions about Tara DeSilva
Answered from the filings on this page, as of the latest one.
Is Tara DeSilva buying or selling?
Not in the last 12 months. Tara DeSilva's latest open-market trade on SEC Form 4 was bought $1,305 of ZSQR on Jan 12, 2024.
How did Tara DeSilva's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Tara DeSilva has 0.
Where does Tara DeSilva file Form 4?
Tara DeSilva has filed Form 4 at ZSQR (Coeptis Therapeutics Holdings, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.